Laxxon Medical to Participate in 25th Annual Needham Growth Conference

Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th Annual Needham Growth Conference at the Lotte New York Palace Hotel on January 10-12, 2023.

Helmut Kerschbaumer, CEO/Chairman, and Alexander Ruckdaeschel, Chief Strategy Officer, will hold one-on-one meetings with institutional, private equity, and venture capital investors throughout the day on January 12, 2023.

About Laxxon Medical Corporation

Laxxon Medical is a pharma-technology company pioneering innovative 3D screen-printed pharmaceutical solutions through SPID®-Technology (Screen Printing Innovational Drug Technology), an additive 3D screen printing technology and manufacturing process. Laxxon Medical holds the exclusive worldwide rights to the use and application of SPID®-Technology for developing, manufacturing, and commercializing pharmaceutical dosage forms.

See the original press release here.

---

Investor Contact:

Alexander Ruckdaeschel Chief Strategy Director a.ruckdaeschel@laxxonmedical.com

Media Contact:

Frances Hoggard Communications Manager f.hoggard@laxxonmedical.com

---